MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
A ReymondierA-M Schott

Abstract

Adequate vitamin D/calcium supplementation during osteoporosis (OP) treatments seems insufficient. This cohort study within a national claims database evaluated calcium/vitamin D co-prescription in postmenopausal women initiating an OP treatment. A high co-prescription rate was observed with three quarters of women supplemented with calcium and/or vitamin D in agreement with current recommendations. Adequate calcium/vitamin D supplementation should be taken in combination with antiresorptive drugs in OP treatment. Despite guidelines, supplementation appears to be insufficient. The objective of this study was to describe and estimate co-prescription rates of calcium/vitamin D among postmenopausal women initiating an OP treatment. All women over 50 years with a first claim for a bisphosphonates, raloxifene, or strontium prescription filled between May and August 2010 were included in a retrospective cohort study. Data source was the health insurance claims database of the Rhône-Alpes area. Among 4,415 women, 77.0 % had co-prescription of calcium or vitamin D with initial OP treatment, of which 2,150 (49.7 %) had both calcium and vitamin D. The proportion of women with calcium and/or vitamin D (81.7 %) was significantly higher whe...Continue Reading

References

Apr 8, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S BoonenJ-Y Reginster
May 13, 2004·Revue D'épidémiologie Et De Santé Publique·P Fender, A Weill
Mar 16, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M RossiniUNKNOWN Treatment of Osteoporosis in clinical Practice (TOP) Study Group
Jan 20, 2007·Drugs & Aging·Alexandra PapaioannouJonathan D Adachi
Jun 15, 2007·Current Medical Research and Opinion·David A HanleyShuvayu S Sen
Jul 31, 2007·Drugs & Aging·Francis BlotmanAbdelkader El Hasnaoui
Feb 13, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisUNKNOWN European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Apr 1, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·L HuotA-M Schott
Jun 14, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S AdamiM Rossini
Feb 26, 2009·Pharmacoepidemiology and Drug Safety·Pernelle NoizeAnnie Fourrier-Réglat
Mar 20, 2009·Joint, Bone, Spine : Revue Du Rhumatisme·Eric LespessaillesAnne-Françoise Gaudin
Jan 12, 2010·Menopause : the Journal of the North American Menopause Society
Feb 4, 2010·Pharmacoepidemiology and Drug Safety·Karin Martin-Latry, Bernard Bégaud
Feb 27, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Patrice FardelloneAnne-Françoise Gaudin
Jul 6, 2010·Revue D'épidémiologie Et De Santé Publique·P TuppinY Merlière
Sep 8, 2010·Current Osteoporosis Reports·Farhan A Syed, Alvin C Ng
Jan 8, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Cyrille B ConfavreuxThierry Thomas
Jan 8, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Nadia MehsenMichel Laroche
Jan 14, 2011·BMC Musculoskeletal Disorders·Bernard CortetFrançois-Emery Cotté
Jan 19, 2011·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Feb 18, 2011·European Journal of Clinical Pharmacology·Linda BrewerAlan Moore
Apr 1, 2011·Lancet·Tilman D RachnerLorenz C Hofbauer

❮ Previous
Next ❯

Citations

Mar 29, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H M MacdonaldA J Black
Oct 21, 2014·BoneKEy Reports·Olivier Lamy, Peter Burckhardt
May 11, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Gabriel Sanfélix-GimenoIsabel Hurtado
Apr 17, 2015·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E Barrett-ConnorB S Stolshek
May 13, 2015·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C KlopF de Vries

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.